文献速递瘢痕与激光

曲安奈德联合A型肉毒毒素治疗增生性瘢痕与瘢痕疙瘩的疗效:一项Meta分析

Efficacy of triamcinolone acetonide combined with botulinum toxin A in the treatment of hypertrophic scars and keloids: A meta-analysis.
PubMed 文献 · Burns · 2024-08-24

该Meta分析检索截至2023年9月的随机对照试验,纳入11项研究共561例患者,评估曲安奈德(TCA)联合A型肉毒毒素(BTA)治疗增生性瘢痕与瘢痕疙瘩的疗效与安全性。结果显示联合组有效率和温哥华瘢痕量表评分均优于对照组,视觉模拟量表评分也显著改善,但瘢痕厚度两组无统计学显著差异。作者认为联合治疗有效性高但对瘢痕厚度影响有限,未来需进一步探索异质性来源并验证长期效果与安全性。

要点

  • BTA+TCA组有效率为对照组的1.28倍(RR=1.28,95%CI 1.14-1.44)。
  • BTA+TCA组视觉模拟量表评分较对照组降低(WMD=-1.69,95%CI -2.72至-0.66)。
  • BTA+TCA组温哥华瘢痕量表评分较对照组降低(WMD=-1.46,95%CI -1.90至-1.02)。

核心结论

  • BTA联合TCA在瘢痕治疗中显示出高有效性,但对瘢痕厚度的影响有限。
  • 未来研究应进一步探索异质性来源,并验证该疗法的长期效果与安全性。

研究设计与样本

  • Meta分析,检索Cochrane Library、Embase、PubMed、Web of Science和CNKI数据库中2023年9月前发表的随机对照试验。
  • 共纳入11项研究,合计561例患者。
  • 计算合并加权均数差(WMD)、合并风险比(RR)及95%置信区间(CI)。

主要发现

  • BTA+TCA组与对照组有效率的差异有统计学意义(RR=1.28,95%CI 1.14-1.44)。
  • BTA+TCA组视觉模拟量表评分较对照组显著改善(WMD=-1.69,95%CI -2.72至-0.66)。
  • BTA+TCA组温哥华瘢痕量表评分较对照组显著改善(WMD=-1.46,95%CI -1.90至-1.02)。
  • BTA+TCA组与对照组瘢痕厚度的差异无统计学意义(WMD=-0.11,95%CI -0.30至0.09)。

局限性

  • 未来研究应进一步探索异质性来源。
  • 未来研究应验证该疗法的长期效果与安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This meta-analysis aims to evaluate the efficacy and safety of triamcinolone acetonide (TCA) combined with botulinum toxin type A (BTA) for treating hypertrophic scars and keloids. METHODS: A comprehensive search of randomized controlled trials published before September 2023 was conducted across the Cochrane Library, Embase, PubMed, Web of Science, and CNKI databases. The analysis involved calculating pooled weighted mean difference (WMD), pooled risk ratios (RR), and 95 % confidence intervals (CI). RESULTS: Inclusive of 11 studies with a total of 561 patients, the meta-analysis revealed a statistically significant difference in the effective rate between the BTA+ TCA and control groups (RR = 1.28, 95 % CI = 1.14-1.44). Moreover, BTA+ TCA demonstrated a significant improvement in Visual Analog Scale scores (WMD = -1.69, 95 % CI = -2.72 - -0.66) and Vancouver Scar Scale scores (WMD = -1.46, 95 % CI = -1.90 - -1.02) compared to the control group. However, no statistically significant difference in scar thickness was observed between the BTA+ TCA and control groups (WMD = -0.11, 95 % CI = -0.30 - 0.09). CONCLUSION: This meta-analysis showed that the combined use of BTA and TCA demonstrates high effectiveness in scar treatment, but its influence on scar thickness is limited. Future research should further explore the sources of heterogeneity and validate the long-term effects and safety of this therapy.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Shi J, Zhang S, Zhang Z, et al. Efficacy of triamcinolone acetonide combined with botulinum toxin A in the treatment of hypertrophic scars and keloids: A meta-analysis. Burns. 2024. PMID: 39447283. doi:10.1016/j.burns.2024.08.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。